management of common medical emergencies in myeloma patients
Last reviewed 01/2018
Management of common medical emergencies in myeloma patients
Hyperviscosity
- may be seen in patients with high serum paraproteins levels (especially those of IgA and IgG3 type)
- patients have blurred vision, headaches, mucosal bleeding and dyspnoea due to heart failure
- in symptomatic patients
- treat with therapeutic plasma exchange with saline fluid replacement
- if plasmapheresis is not immediately available consider isovolaemic venesection with saline replacement as a holding measure
- if transfusion is essential, exchange transfusion should be performed
- effective treatment for myeloma should be started promptly (1)
Hypercalcaemia
- up to 30% of patients may present with hypercalcaemia, majority in the context of active disease
- acute hypercalcaemia may present with CNS dysfunction (confusion, coma and obtundation), muscle weakness, pancreatitis, constipation, thirst, polyuria, shortening of the Q-T interval on ECG and acute renal insufficiency
- other causes such as hyperparathyroidism should be considered as well in these patients
- treatment of hypercalcaemia should be initiated as soon as possible (to
minimise long term renal damage) along with the treatment of underlying disease
o in mild hypercalcaemia (corrected calcium 2.6-2.9 mmol/l) re-hydrate with
oral and /or iv fluids
- in moderate-severe hypercalcaemia (corrected calcium >2.9 mmol/l) re-hydrate with intravenous fluids and give furosemide if required
- all patients with moderate-severe hypercalcaemia should receive a bisphosphonate (1)
Cord compression
- is a medical emergency which requires rapid diagnosis and treatment
- seen in 5% of the patients
- clinical features varies but commonly include sensory loss, paraesthesiae, limb weakness, walking difficulty and sphincter disturbance
- MRI should be obtained immediately and neurosurgical or spinal surgical / clinical oncology consultation obtained
- treatment methods include
- for non-bony lesions - local radiotherapy is the treatment of choice, should be started as soon as possible (preferably within 24 hours of the diagnosis)
- for bony compression and/or to stabilize the spine - surgery is carried out for emergency decompression
- effective systemic therapy should be started promptly (1)
Early infection
- there is an increased incidence of early infection in myeloma patients associated with deficits in both humoral and cellular immunity
- around 10% of patients die of infective causes within 60 days of diagnosis
- neutropenia is not usually associated with early infection
- management of early infections include:
- any febrile myeloma patient should be treated promptly with broad-spectrum antibiotics. Intravenous antibiotics are required for severe systemic infection or neutropenic sepsis
- Aminoglycosides should be avoided, if possible
- there is insufficient evidence to recommend the routine use of prophylactic antibiotics (1)
Reference: